Skip Navigation



Schizophrenia Bulletin Advance Access published online on October 5, 2005

Schizophrenia Bulletin, doi:10.1093/schbul/sbj007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
32/1/166    most recent
sbj007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Haroun, N.
Right arrow Articles by Cadenhead, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haroun, N.
Right arrow Articles by Cadenhead, K. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.

Article

Risk and Protection in Prodromal Schizophrenia: Ethical Implications for Clinical Practice and Future Research

Nasra Haroun 1, Laura Dunn 2, Ansar Haroun 3, and Kristin S. Cadenhead 2*
1 University of California, San Diego
2 University of California, San Diego; Veterans Affairs San Diego Healthcare System
3 University of California, San Diego; San Diego Superior Court; University of San Diego

* To whom correspondence should be addressed.
Kristin S. Cadenhead, E-mail: kcadenhead{at}ucsd.edu


   Abstract

Over the last decade schizophrenia researchers have turned their attention to earlier identification in the prodromal period of illness. A greater understanding of both risk and protective factors can lead to improved prevention and treatment strategies in this vulnerable population. This research, however, has far-reaching ethical implications. One year follow-up data from 50 individuals who met established criteria for a prodromal state is used to illustrate ethical issues that directly affect clinicians and future research strategies. At 1-year follow-up, the psychotic transition rate was 13%, but it increased in subsequent years with smaller sample sizes. One-half developed an affective psychosis. The converted sample was older (p > 0.05) than the nonconverted sample and more likely to have a premorbid history of substance abuse, as well as higher clinical ratings on "subsyndromal" psychotic items (delusional thinking, suspiciousness, and thought disorder). Despite a lack of conversion, the nonconverted sample remained symptomatic and had a high rate of affective and anxiety disorders with evidence of functional disability. This conversion rate is relatively low compared to similar studies at 1 year. Specific risk factors were identified, but these findings need to be replicated in a larger cohort. By examining the rate of conversion and nonconversion in this sample as an example, we hope to contribute to the discussion of implications for clinical practice and the direction of future research in the schizophrenia prodrome. Finally, our data strengthen the evidence base available to inform the discussion of ethical issues relevant to this important research area.

Keywords: first episode; substance abuse; familial.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Schizophr BullHome page
S. W. Woods, J. Addington, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, R. Heinssen, D. O. Perkins, L. J. Seidman, M. T. Tsuang, E. F. Walker, et al.
Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study
Schizophr Bull, September 1, 2009; 35(5): 894 - 908.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
U. Meyer, E. Spoerri, B. K. Yee, M. J. Schwarz, and J. Feldon
Evaluating Early Preventive Antipsychotic and Antidepressant Drug Treatment in an Infection-Based Neurodevelopmental Mouse Model of Schizophrenia
Schizophr Bull, October 8, 2008; (2008) sbn131v1.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
V. A. Mittal, C. Neumann, M. Saczawa, and E. F. Walker
Longitudinal Progression of Movement Abnormalities in Relation to Psychotic Symptoms in Adolescents at High Risk of Schizophrenia
Arch Gen Psychiatry, February 1, 2008; 65(2): 165 - 171.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
T. D. Cannon, K. Cadenhead, B. Cornblatt, S. W. Woods, J. Addington, E. Walker, L. J. Seidman, D. Perkins, M. Tsuang, T. McGlashan, et al.
Prediction of Psychosis in Youth at High Clinical Risk: A Multisite Longitudinal Study in North America
Arch Gen Psychiatry, January 1, 2008; 65(1): 28 - 37.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
O. D Howes, S. Weinstein, P. Tabraham, L. Valmaggia, M. Broome, and P. McGuire
Street slang and schizophrenia
BMJ, December 22, 2007; 335(7633): 1294 - 1294.
[Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
A. R. YUNG and P. D. McGORRY
Prediction of psychosis: setting the stage
The British Journal of Psychiatry, December 1, 2007; 191(51): s1 - s8.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
O. D. HOWES, A. J. MONTGOMERY, M. ASSELIN, R. M. MURRAY, P. M. GRASBY, and P. K. McGUIRE
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
The British Journal of Psychiatry, December 1, 2007; 191(51): s13 - s18.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
T. H. McGlashan, J. Addington, T. Cannon, M. Heinimaa, P. McGorry, M. O'Brien, D. Penn, D. Perkins, R. K. R. Salokangas, B. Walsh, et al.
Recruitment and Treatment Practices for Help-Seeking "Prodromal" Patients
Schizophr Bull, May 4, 2007; (2007) sbm025v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
C. U. Correll, J. B. Penzner, A. M. Frederickson, J. J. Richter, A. M. Auther, C. W. Smith, J. M. Kane, and B. A. Cornblatt
Differentiation in the Preonset Phases of Schizophrenia and Mood Disorders: Evidence in Support of a Bipolar Mania Prodrome
Schizophr Bull, May 2, 2007; (2007) sbm028v1.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
A. R. Yung, H. P. Yuen, G. Berger, S. Francey, T.-C. Hung, B. Nelson, L. Phillips, and P. McGorry
Declining Transition Rate in Ultra High Risk (Prodromal) Services: Dilution or Reduction of Risk?
Schizophr Bull, May 1, 2007; 33(3): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
T. D. Cannon, B. Cornblatt, and P. McGorry
Editor's Introduction: The Empirical Status of the Ultra High-Risk (Prodromal) Research Paradigm
Schizophr Bull, May 1, 2007; 33(3): 661 - 664.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.